-
1
المؤلفون: Giuseppe Montalto, Manfredi Rizzo, Khalid Al-Rasadi
المساهمون: Rizzo, M, Montalto, G, Al-Rasadi, K.
مصطلحات موضوعية: cardiovascular risk, medicine.medical_specialty, medicine.medical_treatment, Population, cardiovascular risk, dyslipidemia, non-alcoholic fatty liver disease, therapy, Disease, Overweight, dyslipidemia, fatty liver disease, treatment, Chronic liver disease, Bioinformatics, Internal medicine, Fatty Acids, Omega-3, medicine, Humans, Pharmacology (medical), education, Dyslipidemias, chemistry.chemical_classification, Pharmacology, education.field_of_study, therapy, business.industry, Insulin, Medicine (all), Fatty liver, dyslipidemia, Fibric Acids, nutritional and metabolic diseases, non-alcoholic fatty liver disease, General Medicine, medicine.disease, Atherosclerosis, Endocrinology, chemistry, medicine.symptom, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Dyslipidemia, Polyunsaturated fatty acid
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb38bca52712594924264c48cfd9d70
http://hdl.handle.net/10447/169645